Immune Classification Tool for Determining Survival Outcomes in Cancer
案件概要
出願人
London Health Sciences Centre Research Inc.; The Regents of the University of California
発明者
Yu Fan Zeng; Anthony Nichols; John Barrett; Paul Boutros; Joseph Mymryk
IPC分類
CPC分類
An immune classification tool useful for determining survival outcomes in cancer patients based on the abundance in gene expression of CD3E, ZAP70 and IRF4 in a cancer tissue sample. The immune classification tool is able to stratify cancer patients, including HPV+HNSCC, HPV−HNSCC and cervical cancer patients, into the three immune groups (immune rich, immune desert, and mixed) that are strongly associated with disease-free survival.
原文（中国語）
An immune classification tool useful for determining survival outcomes in cancer patients based on the abundance in gene expression of CD3E, ZAP70 and IRF4 in a cancer tissue sample. The immune classification tool is able to stratify cancer patients, including HPV+HNSCC, HPV−HNSCC and cervical cancer patients, into the three immune groups (immune rich, immune desert, and mixed) that are strongly associated with disease-free survival.
外部リソース